digestive enzymes for glp 1 users SoWell Protein Digestive Enzymes and Ozempic: Safety,

A 2025 Nature Medicine study of 200,000+ patients found: 2.02.5x higher risk of drug-induced pancreatitis Higher incidence of kidney stones and arthritis Chronic pancreatitis can permanently damage the pancreas and raises long-term cancer risk

The backdrop is the 20222025 GLP-1 drug shortages, which legally allowed compounding facilities to produce copies of those drugs and the question of whether some facilities are still compounding at scale now that those shortages have ended

February 21, 2024

Understanding when these side effects are manageable versus when they require medical attention is essential for safe and effective treatment